glp-1 ra drugs Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Group Starts for GLP-1 RA

At the same time, Lillys tirzepatide products (Mounjaro for type 2 diabetes and ZepBound for obesity) have surged

The pharmacodynamics of ALT-801, a GLP-1/glucagon receptor dual agonist optimized for NASH and weight loss, were compared to semaglutide (GLP-1 receptor agonist) and elafibranor (peroxisome proliferator-activated receptor, PPAR-/, agonist) in a biopsy-confirmed, diet-induced obese (DIO) mouse model of NASH (DIO-NASH)

However, a small percentage of cases are familial, resulting from mutations in specific genes [82]

But if youre trying to wrap your head around what these drugs are, how they work, and what the risks versus rewards look like, we think its a pretty good place to start

Clinician Support: A licensed clinician oversees your treatment, manages your prescription, and is available for ongoing guidance throughout your program